BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12467235)

  • 21. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
    Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activation.
    Baumann RP; Seow HA; Shyam K; Penketh PG; Sartorelli AC
    Oncol Res; 2005; 15(6):313-25. PubMed ID: 16408696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine in three-dimensional collagen cultures of normal human breast epithelial cells.
    Hamdan MA; Guzman RC; Yang J; Beattie C; Mascharack P; Nandi S
    Carcinogenesis; 1992 Oct; 13(10):1743-9. PubMed ID: 1423833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells.
    Liu L; Lee K; Schupp J; KoƧ ON; Gerson SL
    Clin Cancer Res; 1998 Feb; 4(2):475-81. PubMed ID: 9516939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
    Wedge SR; Porteous JK; Newlands ES
    Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice.
    Ewesuedo RB; Wilson LR; Friedman HS; Moschel RC; Dolan ME
    Cancer Chemother Pharmacol; 2001; 47(1):63-9. PubMed ID: 11221964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.
    Dolan ME; Norbeck L; Clyde C; Hora NK; Erickson LC; Pegg AE
    Carcinogenesis; 1989 Sep; 10(9):1613-9. PubMed ID: 2766456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of the optimal modulatory dose of O6-benzylguanine in patients with surgically resectable tumors.
    Dolan ME; Posner M; Karrison T; Radosta J; Steinberg G; Bertucci D; Vujasin L; Ratain MJ
    Clin Cancer Res; 2002 Aug; 8(8):2519-23. PubMed ID: 12171878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.
    Wedge SR; Porteus JK; May BL; Newlands ES
    Br J Cancer; 1996 Feb; 73(4):482-90. PubMed ID: 8595163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.
    Spiro TP; Gerson SL; Liu L; Majka S; Haaga J; Hoppel CL; Ingalls ST; Pluda JM; Willson JK
    Cancer Res; 1999 May; 59(10):2402-10. PubMed ID: 10344750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-linking of the DNA repair protein Omicron6-alkylguanine DNA alkyltransferase to DNA in the presence of antitumor nitrogen mustards.
    Loeber R; Michaelson E; Fang Q; Campbell C; Pegg AE; Tretyakova N
    Chem Res Toxicol; 2008 Apr; 21(4):787-95. PubMed ID: 18324787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.
    Dolan ME; Pegg AE; Dumenco LL; Moschel RC; Gerson SL
    Carcinogenesis; 1991 Dec; 12(12):2305-9. PubMed ID: 1747932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.
    Pegg AE; Swenn K; Chae MY; Dolan ME; Moschel RC
    Biochem Pharmacol; 1995 Oct; 50(8):1141-8. PubMed ID: 7488227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide.
    Kanzawa T; Bedwell J; Kondo Y; Kondo S; Germano IM
    J Neurosurg; 2003 Dec; 99(6):1047-52. PubMed ID: 14705733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
    Marathi UK; Dolan ME; Erickson LC
    Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O6-Benzylguanine potentiates BCNU but not busulfan toxicity in hematopoietic stem cells.
    Westerhof GR; Down JD; Blokland I; Wood M; Boudewijn A; Watson AJ; McGown AT; Ploemacher RE; Margison GP
    Exp Hematol; 2001 May; 29(5):633-8. PubMed ID: 11376877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
    Schilsky RL; Dolan ME; Bertucci D; Ewesuedo RB; Vogelzang NJ; Mani S; Wilson LR; Ratain MJ
    Clin Cancer Res; 2000 Aug; 6(8):3025-31. PubMed ID: 10955780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential degradation rates of inactivated alkyltransferase in blood mononuclear cells and tumors of patients after treatment with O(6)-benzylguanine.
    Liu L; Spiro TP; Qin X; Majka S; Haaga J; Schupp J; Willson JK; Gerson SL
    Clin Cancer Res; 2001 Aug; 7(8):2318-24. PubMed ID: 11489807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts.
    Lukash LL; Boldt J; Pegg AE; Dolan ME; Maher VM; McCormick JJ
    Mutat Res; 1991; 250(1-2):397-409. PubMed ID: 1944354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous protection of G156A methylguanine DNA methyltransferase gene-transduced hematopoietic progenitors and sensitization of tumor cells using O6-benzylguanine and temozolomide.
    Reese JS; Davis BM; Liu L; Gerson SL
    Clin Cancer Res; 1999 Jan; 5(1):163-9. PubMed ID: 9918215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.